As technology advances, the practical use of secondary RWD has grown exponentially and is now fueling a new wave of digital disruption.

Advances in technology, from the massive storage and computing options now available through cloud computing to advances in algorithmic processing, have empowered organizations to consider secondary Real-World Data (RWD) sources as viable options for evidence generation across a wide spectrum of use cases. Within the last few years, the exploration and practical use of secondary data has grown exponentially and is now fueling a new wave of digital disruption.

New insights never thought possible are now becoming achievable. The challenge presented with this new era of data use sees unprepared organizations spending massive amounts of resources on secondary data for specific one-off use cases, without thought to how those data may be harmonised across the organization, resulting in large-scale data silos throughout the enterprise. Data silos bring an inherent inefficiency and create roadblocks to achieving the desired success.

In this free webinar, learn about the most common barriers to harmonised RWD and ways to overcome them. Attendees will get insights on:

  • How duplicate data environments, redundant data subscriptions and siloed data access can hinder ROI for real-world evidence generation
  • Practical solutions for developing a collaborative data strategy
  • The benefits of using one centralised data technology platform for RWD

Register Today

To register for this free webinar, visit our webinar partner, xTalks, and complete a one time only form.

Register

Presenters

Bill Row, MBA, MS

Bill Row, MBA, MS

Divisional Principal, Real World Evidence Strategy & Analytics, Commercialisation & Outcomes Services, ICON

Bill Row is a seasoned drug development professional with over 20 years’ experience in study design and execution, portfolio management, department building, strategic planning and relationship management. Bill is a recognized leader in the design, operational strategy, commercial and technology applications of RWE at both pharma and contract research organisations. He has held leadership roles in executive management, clinical operations, project management and strategy and innovation, with an emphasis on late phase and real-world evidence programs.

As Divisional Principal, Real World Evidence Strategy and Analytics at ICON, Bill leads the RWE Strategy capability; providing innovative data and evidence strategies to produce valuable insights and more informed decisions to drive value demonstration for our biopharmaceutical and device customers

Bruce Capobianco

Bruce Capobianco

Senior Director, Technology, Real World Evidence Strategy & Analytics, Commercialisation & Outcomes Services, ICON

Bruce has over 15 years of experience in business technology and digital transformations.  At ICON, he leads a global team to develop, enhance and maintain technology solutions in the RWE group in order to deliver highly effective tools and services for ICON customers. He has a proven track record of leveraging technology as a facilitator for new innovative business capabilities.  He is a sought after leader in the design and implementation of SaaS based “Big Data” technology analytical platforms.  He has held various leadership roles in development, infrastructure, architecture and innovations teams across several verticals.

Prior to joining ICON, at Syneos Health, Bruce led a global team of architects, developers, PMs and QA staff to drive disruptive technology trends for competitive advantage.  Bruce holds a BS in Computer Science/Mathematics from Salem State University, coupled with earning a vast collection of industry preferred technology certifications.  Bruce is very active with community blogging and whitepaper development, especially on Cognitive Technologies: The Real Opportunities for Business Disruption.

Anand Dubey, PhD

Senior Manager, Ecosystem Innovation, Real World Evidence, Business Solutioning, Saama Technologies

Anand Dubey joined Saama Technologies in April 2017 as Business Solutions Architect, Real World Evidence and is responsible for RWE product and solution development for clinical operational group. Prior to joining Saama, Anand worked at Genpact, a global professional services firm, where he focused on technology-enabled solutions for clinical, data sciences, and commercial team.